Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Manza A. Agovi"'
Autor:
Afiba Manza-A Agovi, Caitlin T. Thompson, Kevin J. Craten, Esther Fasanmi, Meng Pan, Rohit P. Ojha, Erika L. Thompson
Publikováno v:
Implementation Science Communications, Vol 5, Iss 1, Pp 1-11 (2024)
Abstract Background Long-acting injectable cabotegravir plus rilpivirine (LAI CAB/RPV) has several potential benefits over daily oral formulations for HIV treatment, including the potential to facilitate long-term adherence and reduce pill fatigue. W
Externí odkaz:
https://doaj.org/article/00cf97ea2cd54d16bfcb2508621911db
Autor:
Meng Pan, Afiba Manza-A. Agovi, Ifedioranma O. Anikpo, Esther O. Fasanmi, Erika L. Thompson, Jaquetta M. Reeves, Caitlin T. Thompson, Marc E. Johnson, Vitaly Golub, Rohit P. Ojha
Publikováno v:
Preventive Medicine Reports, Vol 33, Iss , Pp 102175- (2023)
The American College of Cardiology (ACC)/American Heart Association (AHA) guidelines were updated in 2018 to explicitly recommend statin use for primary cardiovascular disease prevention among people living with HIV (PLWH), but little is known about
Externí odkaz:
https://doaj.org/article/5b91020e57ad4b13af81b4d385fa5fa8
Autor:
Afiba Manza-A. Agovi, Ifedioranma Anikpo, Matthew J. Cvitanovich, Kevin J. Craten, Eve O. Asuelime, Rohit P. Ojha
Publikováno v:
Preventive Medicine Reports, Vol 20, Iss , Pp 101266- (2020)
Safety-net health systems are a primary source of care for socioeconomically disadvantaged individuals who may be eligible for HIV pre-exposure prophylaxis (PrEP) and are priority groups under the Ending the HIV Epidemic (EHE) initiative. Nevertheles
Externí odkaz:
https://doaj.org/article/361942df9b6441108ebea7dbcbe8694f
Autor:
Meng Pan, Afiba Manza-A. Agovi, Ifedioranma O. Anikpo, Esther O. Fasanmi, Erika L. Thompson, Jaquetta M. Reeves, Caitlin T. Thompson, Marc E. Johnson, Vitaly Golub, Rohit P. Ojha
Publikováno v:
SSRN Electronic Journal.
Autor:
Matthew J. Cvitanovich, Esther O. Fasanmi, Ifedioranma Anikpo, Afiba Manza-A. Agovi, Julia L. Marcus, Rohit P. Ojha
Publikováno v:
J Acquir Immune Defic Syndr
INTRODUCTION Safety-net health systems are key settings for HIV pre-exposure prophylaxis (PrEP) implementation, but little evidence is available about the frequency of PrEP prescribing in safety-net settings. We assessed PrEP prescribing among people
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d083454279b843ee241c00da5cb03ce
https://europepmc.org/articles/PMC8527831/
https://europepmc.org/articles/PMC8527831/
Publikováno v:
Annals of Epidemiology. 75:84
Autor:
Afiba Manza-A. Agovi, Frank Lonergan, Marc Johnson, Ifedioranma Anikpo, Rohit P. Ojha, Matthew J. Cvitanovich
Publikováno v:
HIV medicine. 22(10)
Objectives Little is known about the external validity of the Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) model for predicting cardiovascular disease (CVD) risk among people living with HIV (PLWH). We aimed to evaluate the performanc
Autor:
Kevin J. Craten, Afiba Manza-A. Agovi, Matthew J. Cvitanovich, Rohit P. Ojha, Ifedioranma Anikpo, Eve O. Asuelime
Publikováno v:
Preventive Medicine Reports, Vol 20, Iss, Pp 101266-(2020)
Preventive Medicine Reports
Preventive Medicine Reports
Highlights • Little is known about barriers to PrEP prescribing in safety-net settings. • We identified low provider knowledge of PrEP as a barrier to PrEP prescribing. • PrEP eligibility, side effects and adherence concerns were key unmet know
Autor:
Andrew D. Maher, Tuli Nakanyala, Shaan D. Chaturvedi, Afiba Manza-A Agovi, Souleymane Sawadogo, Melody Regina Chipadze, Simon Agolory, Nicholus Mutenda, Dimitri Prybylski, Anna Jonas, Ndapewa Hamunime, Adam Wolkon, Annastasia Tizora, Sadhna V. Patel, Asen Mwandemele, Charity Ntema, Karen M. Banda, Willi McFarland, David W. Lowrance, Grace Sinvula
Publikováno v:
JMIR Public Health and Surveillance, Vol 6, Iss 2, p e17107 (2020)
JMIR Public Health and Surveillance
JMIR Public Health and Surveillance
Background Direct measures of HIV incidence are needed to assess the population-level impact of prevention programs but are scarcely available in the subnational epidemic hotspots of sub-Saharan Africa. We created a sentinel HIV incidence cohort with
Autor:
Andrew D Maher, Tuli Nakanyala, Nicholus Mutenda, Karen M Banda, Dimitri Prybylski, Adam Wolkon, Anna Jonas, Souleymane Sawadogo, Charity Ntema, Melody Regina Chipadze, Grace Sinvula, Annastasia Tizora, Asen Mwandemele, Shaan Chaturvedi, Afiba Manza-A Agovi, Simon Agolory, Ndapewa Hamunime, David W Lowrance, Willi Mcfarland, Sadhna V Patel
BACKGROUND Direct measures of HIV incidence are needed to assess the population-level impact of prevention programs but are scarcely available in the subnational epidemic hotspots of sub-Saharan Africa. We created a sentinel HIV incidence cohort with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f230bee9da1a7c09dc79cb752096202d
https://doi.org/10.2196/preprints.17107
https://doi.org/10.2196/preprints.17107